Rudondy P, Ferdani M, Reggi M, Jausseran J M
Department of Cardiovascular Surgery, Hôpital St Joseph, Marseille, France.
Cardiovasc Surg. 1994 Jun;2(3):344-9.
Between February 1991 and October 1991, vena cava filters made of Vascor (Toulon, France) were inserted into 51 patients. The male:female ratio was 29:22 and mean age 74 (range 45-94) years. Diagnosis of thrombophlebitis was established by venography in 48 patients (94%) and ultrasonography in three (6%). Thrombosis was unilateral in 49 patients and bilateral in two, involved the pelvic veins in 38 (75%) and the leg veins in 13 (25%). Of the 51 patients, 17 (33%) presented pulmonary emboli and 12 (24%) had waving supracrural clots. The Vascor umbrella filter is a two-stage stainless-steel device with attachment tabs for anchoring and centering. It can be placed either percutaneously using a 7-gauge French introducer via the jugular, subclavian or brachial vein or surgically. In the present series, placement was achieved percutaneously via the jugular vein, in 49 cases (96%) and surgically in two (4%). Postoperative and follow-up examinations included coagulation tests, Doppler ultrasonography and abdominal radiography. In the immediate postoperative period, one patient developed a pneumothorax which was treated by pleural drainage and five died from cancer within the first month after placement. There were no postoperative accidents and no patient had recurrent embolism. In three patients, the filter tilted 30 degrees and in one caval thrombosis was identified. Follow-up examinations were performed in 46 patients, with a mean duration of 12 months. Ten patients have died. Caval thrombosis occurred in two patients (4%) but proximal migration of the filter and recurrence of pulmonary embolism have not been observed.
1991年2月至1991年10月期间,51例患者植入了由法国土伦的Vascor公司生产的腔静脉滤器。男女比例为29:22,平均年龄74岁(范围45 - 94岁)。48例(94%)患者通过静脉造影确诊为血栓性静脉炎,3例(6%)通过超声检查确诊。49例患者血栓为单侧,2例为双侧;38例(75%)累及盆腔静脉,13例(25%)累及腿部静脉。51例患者中,17例(33%)出现肺栓塞,12例(24%)有波动的膈上血栓。Vascor伞形滤器是一种两级不锈钢装置,带有用于锚定和定位的附着片。它可以通过7号法国导入器经颈静脉、锁骨下静脉或肱静脉经皮放置,也可以通过手术放置。在本系列中,49例(96%)通过经颈静脉经皮放置,2例(4%)通过手术放置。术后及随访检查包括凝血试验、多普勒超声检查和腹部X线检查。术后即刻,1例患者发生气胸,经胸腔引流治疗,5例患者在放置后第一个月内死于癌症。无术后并发症,无患者出现复发性栓塞。3例患者滤器倾斜30度,1例发现腔静脉血栓形成。46例患者进行了随访,平均随访时间为12个月。10例患者死亡。2例患者(4%)发生腔静脉血栓形成,但未观察到滤器近端移位和肺栓塞复发。